GENETIC OBESITY

Clinical trials for GENETIC OBESITY explained in plain language.

Never miss a new study

Get alerted when new GENETIC OBESITY trials appear

Sign up with your email to follow new studies for GENETIC OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Gene-Targeted obesity drug shows promise in phase 3 trial

Disease control Ongoing

This phase 3 trial is testing a drug called setmelanotide in people with obesity linked to certain gene variants (POMC, PCSK1, LEPR, NCOA1, or SH2B1). About 296 participants, aged 6 to 65, will receive either the drug or a placebo to see if it helps reduce body weight. The study …

Matched conditions: GENETIC OBESITY

Phase: PHASE3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:03 UTC

GENETIC OBESITY

Get alerted when new GENETIC OBESITY trials appear

Gene-Targeted obesity drug shows promise in phase 3 trial